Related Experiment Video

Updated: Aug 15, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

[HIV-associated cardiomyopathy]

Till Neumann1, Jana Kondratieva, Frank Breuckmann

  • 1Westdeutsches Herzzentrum, Klinik für Kardiologie, Universität, Essen-Duisburg. till.neumann@uni-essen.de

Herz
|September 20, 2005
PubMed

Insights

Human immunodeficiency virus (HIV) infection can lead to heart problems like cardiomyopathy. Early screening and treatment are crucial for better outcomes in HIV patients with cardiovascular issues.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Pharmacology

Context:

  • Human immunodeficiency virus (HIV) infection is a significant global health concern with frequent cardiovascular complications.
  • Left ventricular dysfunction is a key predictor of mortality in HIV-infected individuals, potentially leading to dilated cardiomyopathy and heart failure.
  • Antiretroviral therapies, while crucial for managing HIV, can pose risks due to mitochondrial toxicity affecting myocardial function.

Purpose:

  • To highlight the prevalence and significance of cardiovascular involvement in HIV infection.
  • To emphasize the diagnostic challenges and potential underestimation of HIV-associated cardiomyopathy.
  • To advocate for increased awareness and routine cardiovascular screening in HIV-infected patients.

Summary:

  • HIV infection is strongly linked to cardiovascular complications, including left ventricular dysfunction and cardiomyopathy, which contribute significantly to morbidity and mortality.
  • While antiretroviral therapies are vital, some drugs can impair heart function through mitochondrial toxicity.
  • HIV-associated cardiomyopathy is often asymptomatic or misdiagnosed, necessitating proactive screening and management.

Impact:

  • Early detection and intervention for cardiovascular complications in HIV patients can reduce mortality and improve quality of life.
  • Routine cardiovascular screening should be integrated into the care of HIV-infected individuals.
  • Understanding the interplay between HIV, antiretroviral therapy, and cardiac health is essential for comprehensive patient management.

More Related Videos

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...